Vaccination

France's Sanofi to seek COVID vaccine approval after delays

French pharmaceuticals giant Sanofi said Wednesday that its COVID-19 vaccine, developed with Britain's GSK, had delivered positive results after nearly a year of delays left it lagging far behind its rivals.

Diseases, Conditions, Syndromes

Pandemic's 'acute phase' could end by midyear: WHO

The head of the World Health Organization said Friday the acute phase of the pandemic could end this year, if around 70 percent of the world gets vaccinated.

Medications

Long-acting cabotegravir not necessarily cost-effective for PrEP

(HealthDay)—For men who have sex with men and transgender women (MSM/TGW) at very high risk for HIV (VHR), the benefits of long-acting injectable cabotegravir (CAB-LA) in terms of life expectancy do not necessarily justify ...

Alzheimer's disease & dementia

Medicare limits coverage of $28,000-a-year Alzheimer's drug

Medicare said Tuesday it will limit coverage of a $28,000-a-year Alzheimer's drug whose benefits have been widely questioned, a major development in the nation's tug-of-war over the fair value of new medicines that offer ...

Medications

US drug prices are costing us more than we think

Aduhelm, the first new Alzheimer's drug in 18 years, could easily become the best-selling drug in Medicare, despite its potential massive cost and tremendous uncertainty about whether the drug even works, says Rachel Sachs, ...

Diseases, Conditions, Syndromes

New omicron variant stokes world fears, triggers travel bans

The discovery of a new coronavirus variant sent a chill through much of the world Friday as nations raced to halt air travel, markets fell sharply and scientists held emergency meetings to weigh the exact risks, which were ...

page 13 from 40